《更新》RAPS/Euro Convergence 2023から
※初出掲載(2023.05.11)
※追記更新(2023.05.12)(2023.05.13)(2023.05.19)(2023.05.20)
5/9と5/10付のRAPSが、自社主催の“Euro Convergence 2023”に関係する記事を複数掲載しています。
関係者および興味のある方は、下記URLsのニュース記事を参照
l 5/10付「Euro Convergence: Experts say safety information should be transparent, accessible」
https://www.raps.org/news-and-
l 5/10付「Euro Convergence 2023: Sessions explore innovation and regulatory challenges」
https://www.raps.org/News-and-
l 5/10付「Navigating the Korean regulatory market and seeing old friends at RAPS Convergence with Joo Hee Kim」
https://www.raps.org/News-and-
l 5/9付「Euro Convergence 2023 delves into MDR/IVDR, EU pharma reform, and more」
https://www.raps.org/News-and-
【5/12付追記更新】
l 5/11付RAPS「Euro Convergence: Experts discuss MDR's early adopter pains」
https://www.raps.org/news-and-
【5/13付追記更新】
l 5/12付RAPS「Euro Convergence: Experts discuss device software deficiencies in the US and EU」
https://www.raps.org/News-and-
l 5/12付RAPS「RAPS Euro Convergence 2023 highlights information transparency, MDR and IVDR transitions and more to a sold-out audience in Amsterdam」
https://www.raps.org/News-and-
【5/19付追記更新】
5/18付RAPS「Euro Convergence: EMA won’t delay drug approval of combo product if diagnostic part doesn’t have CE mark」
https://www.raps.org/news-and-
【5/20付追記更新】
5/19付RAPS「Euro Convergence: Experts call for more IVD-specific guidance during IVDR transition」
https://www.raps.org/news-and-
コメント
/
/
/
コメント